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Protein patterns in six samples from primary vaginal cancers, in five from normal vaginal tissue and in five primary cervical cancers,
were analysed using two-dimensional polyacrylamide gel electrophoresis (2-DE). Protein expression profile was evaluated by
computer-assisted image analysis (PDQUEST) and proteins were subsequently identified using matrix-assisted laser desorption/
ionisation mass spectrometry. The aim was to analyse the protein expression profiles using the hierarchical clustering method in
vaginal carcinoma and to compare them with the protein pattern in cervical carcinoma in order to find a helpful tool for correct
classification and for increased biomedical knowledge. Protein expression data of a distinct set of 33 protein spots were differentially
expressed. These differences were statistically significant (Mann–Whitney signed-Ranked Test, Po0.05) between normal tissue,
vaginal and cervical cancer. Furthermore, protein profiles of pairs of primary vaginal and cervical cancers were found to be very similar.
Some of the protein spots that have so far been identified include Tropomyosin 1, cytokeratin 5, 15 and 17, Apolipoprotein A1,
Annexin V, Glutathione-S-transferase. Others are the stress-related proteins, calreticulin, HSP 27 and HSP 70. We conclude that
cluster analysis of proteomics data allows accurate discrimination between normal vaginal mucosa, primary vaginal and primary
cervical cancer. However, vaginal and cervical carcinomas also appear to be relatively homogeneous in their gene expression,
indicating similar carcinogenic pathways. There might, further, be a possibility to identify tumour-specific markers among the proteins
that are differentially expressed. The results from this study have to be confirmed by more comprehensive studies in the future.
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Primary carcinoma of the vagina (PCV) is a rare disease affecting
predominantly postmenopausal women (Pecorelli, 2001). Histolo-
gically, the majority of PCV consist of squamous cell carcinomas
(Pecorelli, 2001). Owing to the rarity of this disease, little is known
about the aetiological and prognostic factors. Like cervical
carcinomas, PCV has been shown to be associated with HPV,
but only in about 50% of the cases (Daling and Sherman, 1992;
Hildesheim et al (1997)). The prognosis for PCV is quite poor with
an overall 5-year survival rate of about 50%, which is worse than
for cervical carcinoma (Pecorelli, 2001). Early detection is crucial
for the prognosis.
It has been suggested that vaginal and cervical carcinomas have
common aetiology since vaginal tumours often occur as second
primary malignancy in patients with a history of cervical dysplasia
and/or neoplasia or hysterectomy due to these disorders (Choo
and Anderson, 1982; Benedet et al, 1983; Brinton et al, 1990; Eddy
et al, 1991; Kirkbride et al, 1995). In the clinical situation, it is
sometimes difficult to discriminate between cervical and vaginal
carcinomas, especially in patients with prior cervical disease. As
95% of the recurrences of cervical carcinoma occur within 5 years,
many authors have chosen this limit for the distinction between a
recurrent cervical carcinoma and a new primary vaginal carcino-
ma. Correct diagnosis is of importance for the choice of therapy,
prognosis and follow-up. The treatment of choice for primary
cervical carcinoma is surgery, sometimes in combination with
radiotherapy and chemotherapy, whereas radiotherapy alone is the
most common treatment for vaginal carcinoma. The treatment and
prognosis of especially vaginal, but also cervical, carcinomas
mainly depend upon crude histopathological and clinical findings.
There is, thus, a need for additional sensitive markers of
prognostic and therapeutic importance and for classification.
Proteomic studies are widely used in the search for new tumour
markers.
Carcinogenesis is a multistep process leading to the develop-
ment of multiple cell clones and heterogeneity as a result of
tumour cell genetic instability.
Two-dimensional gel electrophoresis (2-DE) has been used to
examine heterogeneity in gene expression in tissues from different
tumours with a view to find tumour-specific molecular markers.
With 2-DE, the complex polypeptide expression is analysed
qualitatively as well as quantitatively. Significant differences in
the polypeptide expression between tumour tissues and the
corresponding normal tissues have been identified, for example
in carcinoma of the bladder (Celis et al, 2000), breast (Franzen
et al, 1997), colon-rectum (Stulik et al, 2001), lung (Schmid et al,
1995) and ovary (Alaiya et al, 1999), leading to a possibility to find
tumour-specific biological markers.
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yCluster analysis, which is a method to describe the similarity
between samples based on their pattern of gene expression (Eisen
et al, 1998), has enabled accurate classification of breast tumour
tissues (Dwek and Alaiya, 2003).
The purpose of this study was to characterise the protein
expression in PCV and to compare the protein profiles with
normal vaginal tissue and primary cervical cancer by using 2-DE in
order to point out similarities or differences that might be helpful
in the diagnosis/differential diagnosis and that could be indicative
for related/unrelated aetiology of these carcinomas.
MATERIALS AND METHODS
Patient tissue samples
A total of 16 tissue biopsies (about 3mm 3mm) were analysed
consisting of five biopsies from normal vaginal epithelium, six
from primary vaginal carcinomas and five from primary cervical
carcinomas. For histopathological data, see Table 1. We included
the normal vaginal tissue to ensure effective comparison with
vaginal cancer. The cervical cancer samples were added in an
attempt to elucidate similarities and differences between cervical
and vaginal cancers at the proteome level. The 11 tumour biopsies
were taken from patients with histopathologically confirmed
diagnosis of either vaginal or cervical cancers.
In order to ensure sample representativity, the samples were
taken by experienced gynaecologists and gynaecological surgeons.
Each tissue sample was macroscopically examined and only
representative, non-necrotic tissue samples were used. Further-
more, both cytological and histological evaluations of all the
samples were made. Only cases in which both histological and
cytological features corresponded with each other were included in
the study. We did not focus on the HPV status in this study
bearing in mind that the limited number of samples will not permit
the drawing of any significant conclusion.
The five normal vaginal biopsies were obtained from the upper
part of the vagina approximately 1cm from the vaginal fornix in
postmenopausal women undergoing total hysterectomy for either
benign disease or endometrial/ovarian carcinoma. All the fresh
tissue samples were snap-frozen in liquid nitrogen until further
processing for 2 DE. All samples were obtained with patient
consent. One of the vaginal cancer cases (V32T) had been treated
with radiation therapy for squamous cell carcinoma of the cervix
35 years ago. None of the other vaginal and cervical cancer cases
had a history of prior gynaecological cancer. None of the vaginal
cancer cases had a history of vaginal or cervical dysplasia or
hysterectomy.
Sample preparation
All the tissue samples were prepared according to a frozen tissue
preparation method (Franzen et al, 1991), with slight modification.
Briefly, whole tissue biopsies were kept frozen in liquid nitrogen
and mechanically homogenised using a pestel and mortal. Each
sample was then dissolved in 300–500ml lysis buffer containing
7 M urea, 2 M thiourea, 4% SDS, reducing agents and protease
inhibitors. Protein concentration was determined using the
Bradford method (Bradford, 1976).
Electrophoresis, scanning and image analysis
For each sample, the equivalent of 100mg total solubilised proteins
dissolved in 350ml volume of rehydration buffer (2% (vv
 1) IPG-
buffer 4-7 linear) was loaded onto a 17cm IPG-strip 4–7 linear
(Bio-Rad, Harcules, CA). This gives better resolution and better
overview of protein spots across the entire chosen pH window. In
addition, the linear gradient also gives a better estimation of the
isoelectric point (pI). Isoelectric focusing was performed for each
individual sample to a total of 45.5kVh using Bio-Rad IEF unit
(201C).
The second dimension was carried out in a 10–13% gradient
SDS gel, and proteins were visualised by silver staining (Rabilloud
et al, 1994). After electrophoresis and staining, only high-quality
gels were used. Occasionally, some samples had to be rerun in
order to obtain comparable quality with other 2-D gels. Stained
gels were scanned at 100mm resolution using a laser densitometer,
and data were analysed using the PDQUESTt software (version
7.1.0, Bio-Rad). Gel images were compared for qualitative and
quantitative differences. Polypeptide quantities were calculated in
parts per million (ppm) of the total integrated optical density.
Mass spectrometry
Protein spots with statistically significant variability in the
expression pattern between normal vaginal epithelium, cervical
and vaginal cancers were selected for identification by mass
spectrometry.
Micropreparative gels for protein identification were prepared
essentially like the analytical gels, except that larger amounts
(750mg) of total proteins were loaded and subjected to isoelectric
focusing. Following 2-DE, gels were stained using Coomassie
colloidal stain. The 2-D gels were analysed by PDQUEST software
and spots of interest were manually excised using a clean sharp
scalpel and transferred into an eppendorf tube. In-gel digestion for
peptide mass fingerprint analysis was carried out manually with
trypsin (Oppermann et al, 2000), and digests were desalted using
Table 1 Clinical and histopathological data
No Sample Type of sample Histology Grade Stage Age
1 V24N Normal vaginal tissue 48
2 V25N Normal vaginal tissue 70
3 V26N Normal vaginal tissue 56
4 V37N Normal vaginal tissue 78
5 V38N Normal vaginal tissue 78
6 V29T Vaginal carcinoma Squamous cell carcinoma I 83
7 V30T Vaginal carcinoma Adenocarcinoma I 54
8 V31T Vaginal carcinoma Squamous cell carcinoma I 89
9 V32T Vaginal carcinoma Squamous cell carcinoma Low I 62
10 V33T Vaginal carcinoma Squamous cell carcinoma Medium I 78
11 V34T Vaginal carcinoma Squamous cell carcinoma High IIB 75
12 Cx40 Cervical carcinoma Squamous cell carcinoma Low IIB 45
13 Cx41 Cervical carcinoma Adenocarcinoma IB2 41
14 Cx42 Cervical carcinoma Squamous cell carcinoma Low IIA 63
15 Cx43 Cervical carcinoma Squamous cell carcinoma Medium IB2 59
16 Cx44 Cervical carcinoma Squamous cell carcinoma Medium IB1 65
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Peptides were eluted in 70% acetonitrile/5% formic acid. The
eluate was mixed 1:1 (vv
 1) with a saturated matrix solution
containing a-cyano-4-hydroxycinnamic acid in 30% acetonitrile/
0.1% trifluoroacetic acid. Mass mapping of tryptic peptides was
performed using MALDI-TOF (above protocol) or Cap-LC-MS/MS
on Micromass Q-TOF Ultima mass spectrometer with LC-packings
pep Map C18, 75mm ID column using a gradient of 7–80% (95%
acetonitrile and 0.1% formic acid) over a period of 35min.
Trypsin fragments of masses 842.50 and 2211.10Da were used as
internal standards for spectra calibration. Data generated were
screened in databases using a mass tolerance p20ppm. The
licensed ProteinLynxt Software (Micromass) or mascot was used
for mass mapping (http://www.matrixscience.com).
The above protocol of MALDI-TOF analysis has a sensitivity of
femtomole amounts of standard 2-DE gel-separated proteins. For a
positive identification of the peptide mass fingerprinting, protein
scores greater than 72 were considered significant (Po0.05), as
calculated by the MASCOT scoring algorithm. In addition, at least
four matching peptides should be found and more than 50% of the
measured masses should match the theoretical peptide fragments.
Data processing/data analysis
Both quantitative and qualitative 2-DE data sets were generated
from PDQUEST, a 2-DE software analysis program.
The data set generated from the matchset based on each
individual sample was imported into J-Express as an Excel test
format in the form of a data table, with rows representing gels and
columns representing spots (Alaiya et al, 2000b). The preprocessed
data were analysed by hierarchical clustering (Golub et al, 1999;
Alaiya et al, 2002) using the J Express pro software v 2.1 available
at http://www.molmine.com.
The J-Express program was primarily designed to analyse
microarray data but equally accepts data sets generated from 2-DE
analysis.
Hierarchical cluster analysis is a statistical method that is based
on measured variables capable of identifying relatively similar
groups of samples. This method is based on the strong assumption
that an appropriate distance measure for comparing cases has been
carefully selected. Thus, the outcome of the clustering analysis
depends on the method of calculation of the distance between
samples being compared. In this study, the degree of similarity was
calculated using the Bray Curtis distance metric and a complete
linkage clustering method. The clustering patterns are then
represented diagrammatically as dendrograms with trees and
branches depicting the degree of sample relatedness. The sets of
genes used in the cluster analysis were selected using Student’s t-
test and the Mann–Whitney ranked test analysis (Po0.05)
between normal vaginal tissue and vaginal cancer samples. A
similar analysis was made between groups of primary vaginal
cancer and primary cervical cancer. These variables were then used
for the classification of the samples into different groups.
Both quantitative and qualitative differences were taken into
account for the statistical analysis.
Correspondence analysis (CA)
We have used correspondence analysis to further evaluate the
same data sets used in hierarchical cluster analysis. This was
considered as a means to test if the observed set of genes can
indeed discriminate the sample groups, bearing in mind the small
sample size of this study.
Correspondence analysis is a computational method that is
similar to principal component analysis (PCA) with potential to
study association between groups of samples based on selected
variables.
The data being subjected to CA is presented as two-dimensional
graphical display. This method is capable of visualising different
structures within a complex data set.
The principle behind the CA is an attempt to group together
objects that are similar while dissimilar objects are separated off.
The degree of similarity or difference is measured by distances
between objects or groups of objects. The analysis has been used to
evaluate different complex microarray data (Fellenberg et al, 2001).
RESULTS
Variation in protein expression between normal vaginal
tissue, vaginal cancer and cervical cancer
Tissue samples from 11 cancer patients and five normal vaginal
tissues were evaluated. The clinical characteristics of the samples
are presented in Table 1. Cells were prepared from fresh-frozen
biopsies and extracts were prepared and analysed by 2-DE for both
qualitative and quantitative differences in the expression of
multiple polypeptides. An average total number of 1373 spots
were resolved on 18 20cm 2-D gels and between 75–82% of the
spots were matched between all the gels. Gel spots were visualised
using silver staining.
Marked quantitative and qualitative changes were observed in
the protein expression pattern between normal samples, vaginal
cancer and cervical cancer samples. In contrast, differential protein
expression data revealed similar expression profiles comparing
vaginal and cervical cancer samples compared with normal
samples (data not shown). This similarity in protein expression
between vaginal and cervical cancers was observed using the
correlation analyses between pairs of samples. When pairs of
vaginal and cervical samples were compared, an average correla-
tion coefficient of 0.68 was observed, compared with 0.62 and 0.55
for pairs of normal vs vaginal cancer and normal vs cervical
cancers, respectively (Table 2). No significant variation was
observed between group correlation among pairs of vaginal cancer
and cervical cancer samples with correlation coefficients of 0.76
and 0.79, respectively.
As shown in Table 1, the materials included one vaginal
adenocarcinoma and one cervical adenocarcinoma. Pairwise
comparison of the adenocarcinoma of the vagina and the
adenocarcinoma of the cervix, with the respective squamous cell
carcinomas, did not show any significant difference in the
correlation coefficient analysis (data not shown).
However, this is in line with the high degree of similarity found
between different subtypes of common epithelial ovarian tumours
where a relatively large number of samples were analysed (Alaiya
et al, 1999).
Representative 2-DE maps from normal vaginal tissue, vaginal
cancer and cervical cancer are shown in Figure 1.
Table 2 Correlation analysis of 2-DE gels from normal, vaginal ancer and
cancer of the cervix
Samples
Correlation
coefficient (r)
Group correlation among normal tissues 0.70 (n¼4 pairs)
Group correlation among vaginal cancers 0.76 (n¼6 pairs)
Group correlation among cervical cancers 0.79 (n¼6 pairs)
Correlation among pairs of vaginal and
cervical cancers
0.68 (n¼13 pairs)
Correlation among pairs of normal and
vaginal cancers
0.62 (n¼10 pairs)
Correlation among pairs of normal and
cervical cancers
0.55 (n¼10 pairs)
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normal vaginal tissue, vaginal cancer and cervical cancer
A total of 67 proteins were differentially expressed in normal
vaginal tissue and vaginal/cervical cancers. The differential
analysis takes into consideration both qualitative and quantitative
changes observed between two sets of samples. This difference was
statistically significant using Mann–Whitney analysis (Po0.05). A
similar analysis was carried out for the three groups of samples
using Student’s t-test analysis, and 94 protein spots differed
significantly.
We have used two simple methods of statistical analysis to select
the variables that may discriminate the three groups of samples,
and proceeded to use these two separate data sets for possible
classification of the samples into their respective groups. The
samples were correctly classified using the hierarchical cluster
analysis (data not shown).
In an effort to reduce the data set to a reasonable number, we
further examined how many protein spots fall in the intersection of
the two data sets, resulting in 33 spots common to both data sets.
Of these 33 protein spots, only 11 were upregulated in both cervical
and vaginal cancers, whereas the remaining 22 spots were
downregulated compared with normal vaginal tissue samples.
The differential expressions of some of these protein spots are
shown in Figure 2.
The 33 spots were used in the cluster analysis of all the samples.
As shown in Figure 3a, all the samples were correctly classified.
Owing to the small sample size of this study, we have used
correspondence analysis to evaluate the same data sets used in
hierarchical cluster analysis. We have used this as a means to test if
the observed set of genes can indeed discriminate the sample
groups. As shown in Figure 3b, the samples clustered distinctively,
and the relatedness of each sample to each other was presented in a
two-dimensional correspondence analysis plot.
This type of analysis allows the identification of potential
protein spots that contribute to the overall clustering of the
samples.
Classification of vaginal and cervical cancer
A total of 23 protein spots were significantly differentially
expressed between pairs of 2-DE gels from only vaginal and
cervical cancers using both the Mann–Whitney and the t-test
(Po0.05). The expression level of this set of 23 protein spots was
used to classify all the samples. Interestingly, all the samples could
be correctly classified into three distinct groups (normal tissue,
vaginal and cervical cancer), Figure 4.
Identification of differentially expressed polypeptides by
mass spectrometry
Protein spots with statistically significant variability in the
expression pattern between normal vaginal epithelium, cervical
and vaginal cancers were selected for identification. Some of these
proteins were identified through matching with 2-DE maps of
proteins already identified, using bench top MALDI-TOF mass
spectrometry. One obvious limitation of working with clinical
samples is getting sufficient material for detailed analysis. There-
fore, the majority of the protein spots in the data sets for cluster
analyses could not be easily identified.
Among the protein spots so far identified are high molecular
weight Tropomyosin 1, cytokeratins 5, 15 and 17, Apolipoprotein
A1, Annexin V, Glutathione-S-transferase. Others are the stress-
related proteins, calreticulin, HSP 27 and HSP 70. Some of the
identified protein spots are shown in Figure 1.
DISCUSSION
This is the first proteomic study concerning vaginal carcinoma in
the literature. As vaginal carcinoma is a rare disease, the numbers
of samples collected in this study are quite few.
In this investigation, we have used hierarchical cluster analysis
based on the protein expression in 2-DE to classify vaginal
carcinoma. All samples could be correctly classified into three
distinct groups (normal tissue, vaginal and cervical cancer). One of
the vaginal cancer cases (V32T) had a history of cervical cancer 35
years ago. This case was originally classified as a new primary
vaginal carcinoma and not as a recurrent cervical carcinoma due to
the long interval between the two carcinomas. In our study, this
classification is supported by the results from the cluster analysis,
where this vaginal cancer case was classified as a vaginal
carcinoma (Figures 3 and 4).
Interestingly, pairs of vaginal cancer and cervical cancer showed
to be relatively homogeneous in their protein expression. Studies
from ovarian carcinoma have shown large heterogeneity between
GST
Annexin V
Calreticulin
HSP 70
HSP 27 Stratifin
Actins
Apolipoprotein A1
TM 1
CK 5
CK 17
CK 10
Serum albumin
pH 4
pH 7
M
r ABC
CK 15
Figure 1 (A–C) Representative examples of 2-DE gels derived from a normal vagina, primary vaginal cancer and primary cancer of the cervix. Whole-cell
lysate was subjected to 2-DE using IPG strips pH 4–7 in the first and 10–13% SDS polyacrylamide gel in the second dimension. Marked are some of the
identified proteins: HSP (heat shock proteins), TM (Tropomyosin), CK (Cytokeratin), GST (glutathione-S-transferase).
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of 0.54 (Alaiya et al, 1999). Studies of breast carcinoma have
likewise shown large intertumoural heterogeneity, with a correla-
tion coefficient of 0.57 for diploid tumours and 0.48 for aneuploid
tumour (Franzen et al, 1996). Consequently, pairs of vaginal and
cervical carcinomas seem to be more homogeneous than pairs of
ovarian and breast carcinomas. This might point at similar genetic
alterations and pathways in the carcinogenesis for vaginal and
cervical carcinomas. This hypothesis is supported by a recent
study by Habermann et al (2003) where comparative genomic
hybridisation was used to analyse the pattern of genomic
imbalances in vaginal squamous cell carcinomas, and revealed
that 70% of vaginal carcinomas carry relative increases in copy
number that map to chromosome arm 3q. As almost all squamous
cell carcinomas of the uterine cervix contain extra copies of
chromosome arm 3q (Heselmeyer et al (1996)), the pattern of
genomic imbalances in PCV is strikingly similar to the one
observed in cervical carcinomas.
According to a recent study by Hellman et al (2003), there seem
to be two types of vaginal carcinoma with age-related aetiology:
one type occurring at younger age with aetiological factors similar
to cervical carcinoma and another type occurring at older age with
different aetiology. This might explain why some vaginal and
cervical carcinomas seem to be more homogeneous in their gene
expression, whereas others are more heterogeneous.
Previous studies have described marked variations in the
expression of cell cycle-related proteins, stress proteins and
members of cytoskeletal proteins between benign and malignant
epithelial tumours of lung, breast, ovary and prostate gel-separated
proteins (Alaiya et al, 2000a; Bergman et al, 2000). Similarly, in
this study, we observed high expression of HSP 27, GST and
Apolipoprotein A1 in both cervical and vaginal cancers compared
with normal vaginal tissue. In contrast, CK 17, a member of a
family of intermediate filament proteins that are characteristic of
epithelial cells as well as tropomyosin 1 (TM 1), were upregulated
in normal vaginal tissue but not in both vaginal and cervical
cancer. Other proteins identified without significantly altered
expression levels between the three sample groups are annexin V,
actins, calreticulin and Stratifin, a member of the 14-3-3 family
proteins.
This observation may indicate that some proteins that are
differentially expressed between benign and malignant epithelial
tumours may not be similarly altered in some other epithelial
tumours such as squamous cell tumours of the vagina and the
cervix. The finding of similar expression pattern of some sets of
proteins in both squamous cell tumours and other epithelial
malignancies may indicate their potential use as markers of
malignancy. In this study, we found that 23 spots enabled
clustering of almost all of the samples. This set of proteins is
evidently interesting for further studies in the search for potential
markers, and may give better insight into the aetiology and
progression of vaginal and cervical cancers.
According to an earlier study in ovarian carcinoma, cluster
analysis of a set of differentially expressed proteins also could be
used as a prognostic tool (Alaiya et al, 2002). However, this
material is too small for survival analysis but might be useful in
future studies.
Most methods of statistical analysis are capable of identifying
potential marker variables that show significant differential
expression between two or more sets of sample groups. However,
data sets used in making predictions between two sample groups
may potentially be susceptible to data over-fit. This problem is
Figure 2 Global analysis of normal vaginal tissue, vaginal cancer and cervical cancer samples using expression data set from 33 polypeptides. Expression
levels in all the samples are measured as ppm. Blue¼normal, red¼vaginal cancer and green¼cervical cancer.
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samples being compared are relatively small. It would, therefore,
be interesting to test the set of genes used in the learning data to
determine whether it can truly differentiate between the two
groups when new samples are added. Unfortunately this was not
possible to test in the present study because of the small sample
size. However, the observed result from the correspondence
analysis is in keeping with the cluster analysis data. Despite the
limited sample size, the observed result is encouraging and
warrants further validation studies.
In conclusion, we have used 2-DE to study protein expression
profiles of vaginal and cervical tissue samples and found that
hierarchical cluster analysis allowed accurate discrimination
between normal vaginal, vaginal and cervical cancer tissue
specimens. This study thus indicates that cluster analysis might
be utilised for correct classification of the tumours. Further, there
might be a possibility to find tumour-specific markers among the
differentially expressed proteins.
Vaginal and cervical carcinomas were also found to be quite
homogeneous in their protein expression, which might indicate
similar aetiological pathways.
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Figure 3 (A) Cluster analysis of normal, vaginal cancer and cervical cancer samples using expression data set from 33 polypeptides. (B) Correspondence
analysis plot of same data set; Blue¼normal, red¼vaginal cancer and green¼cervical cancer.
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